Intrastriatal infusion of the potent dopaminergic trophic factor GDNF promotes significant behavioral improvements in animal models of Parkinson's disease. The mechanisms of action are not fully understood, but include the upregulation of nigrostriatal dopaminergic functions, neuroprotection against some neurotoxins, and over a period of weeks to months, structural restoration on the nigrostriatal dopaminergic system. Another possible mechanism, with extraordinary implications if substantiated, is the neurogenesis of nigral dopamine neurons. The studies in Project 3 focuse on answering three major questions. 1) What is the role of neurogenesis and/or gliogenesis in GDNF- induced functional recovery of the nigrostriatal system? Experiments are designed to critically test the hypothesis that neurogenesis is a principal component of functional recovery in the substantia nigra and putamen. 2) To what extent does GDNF therapy restore normal nigrostriatal dopaminergic circuitry? Structural restoration will be correlated with the measures of functional restoration quantified in Projects 1 and 2 to critically test the hypothesis that the extent of motor behavior recovery in parkinsonian rhesus monkeys receiving GDNF therapy is directly correlated to the structural restoration of the nigrostriatal dopaminergic system. 3) To identify and analyze possible neuropatholoqical sequellae arising from intracerebral GDNF treatment. Antibodies to GDNF have been detected in some advanced Parkinson's disease patients receiving intracerebral administration of the trophic factor. The effects of circulating GDNF antibodies on the adult primate nervous system are not known. Thehypothesis being tested in this specific aim is that there is not anautoimmune loss of GDNF-responsive neurons in adult primates with circulating GDNF antibodies. Five populations of GDNF-responsive neurons will be evaluated in rhesus monkeys receiving intracerebral infusions of GDNF or vehicle. Three of the neuronal populations are in the CNS: midbrain dopamine neurons, Purkinje cells in the cerebellum and motor neurons in the cervical spinal cord. The other two neuronal types are in the PNS: dorsal root ganglion neurons and enteric neurons in the gastrointestinal system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS039787-10
Application #
7904806
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
10
Fiscal Year
2009
Total Cost
$281,952
Indirect Cost
Name
University of Kentucky
Department
Type
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Stenslik, M J; Evans, A; Pomerleau, F et al. (2018) Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques. J Neurosci Methods 303:30-40
Stenslik, Mallory J; Potts, Lisa F; Sonne, James W H et al. (2015) Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease. J Neurosci Methods 251:120-9
Fan, X T; Zhao, F; Ai, Y et al. (2014) Cortical glutamate levels decrease in a non-human primate model of dopamine deficiency. Brain Res 1552:34-40
Fuqua, Joshua L; Littrell, Ofelia M; Lundblad, Martin et al. (2014) Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitro. Peptides 54:1-8
Stephens, Michelle L; Williamson, Anne; Deel, Megan E et al. (2014) Tonic glutamate in CA1 of aging rats correlates with phasic glutamate dysregulation during seizure. Epilepsia 55:1817-25
Littrell, Ofelia M; Granholm, Ann-Charlotte; Gerhardt, Greg A et al. (2013) Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF. Pharmacol Biochem Behav 104:10-9
Littrell, O M; Fuqua, J L; Richardson, A D et al. (2013) A synthetic five amino acid propeptide increases dopamine neuron differentiation and neurochemical function. Neuropeptides 47:43-9
van Bregt, Daniel R; Thomas, Theresa Currier; Hinzman, Jason M et al. (2012) Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat. Exp Neurol 234:8-19
Littrell, Ofelia M; Pomerleau, Francois; Huettl, Peter et al. (2012) Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice. Neurobiol Aging 33:427.e1-14
Stephens, Michelle L; Quintero, Jorge E; Pomerleau, Francois et al. (2011) Age-related changes in glutamate release in the CA3 and dentate gyrus of the rat hippocampus. Neurobiol Aging 32:811-20

Showing the most recent 10 out of 63 publications